Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. United Laboratories International Holdings's
Operating Income
for the
six
months ended in Dec. 2025 was €14 Mil. United Laboratories International Holdings's Interest Expense for the
six
months ended in Dec. 2025 was €-6 Mil.
United Laboratories International Holdings's interest coverage for the quarter that ended in Dec. 2025 was 2.42.
The higher the ratio, the stronger the company's financial strength is.
United Laboratories International Holdings (STU:UNJ) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
United Laboratories International Holdings Interest Coverage Related Terms
United Laboratories International Holdings Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
United Laboratories International Holdings Interest Coverage Chart
United Laboratories International Holdings Annual Data
STU:UNJ vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
United Laboratories International Holdings Interest Coverage vs Drug Manufacturers Industry
United Laboratories International Holdings Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
United Laboratories International Holdings (STU:UNJ) has a Interest Coverage of 2.42 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on United Laboratories International Holdings and its competitors. This is 85% below median its historical median of 15.81. Over the past decade, United Laboratories International Holdings' Interest Coverage has ranged from 2.07 to 89.14. According to the industry distribution chart, United Laboratories International Holdings ranks #225 out of 687 companies in the Drug Manufacturers industry, placing it in the top 32.8%.
Is United Laboratories International Holdings' Interest Coverage too high?
United Laboratories International Holdings' current Interest Coverage of 2.42 is 85% below median its 10-year median of 15.81. Over the past 10 years, this metric has ranged from a low of 2.07 to a high of 89.14. The Drug Manufacturers industry median Interest Coverage is 12.75. United Laboratories International Holdings' value of 2.42 is 81% below this industry median. Based on the distribution chart, United Laboratories International Holdings ranks #225 out of 687 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, United Laboratories International Holdings has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, United Laboratories International Holdings ranks #225 out of 687 companies for Interest Coverage. This puts United Laboratories International Holdings in the upper half of its industry. The industry median Interest Coverage is 12.75. United Laboratories International Holdings' value of 2.42 is 81% below this benchmark. Historically, United Laboratories International Holdings' own Interest Coverage has ranged from 2.07 to 89.14 over the past decade. While the company's 10-year median is 15.81 vs. the industry median of 12.75, United Laboratories International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Laboratories International Holdings's current Interest Coverage of 2.42 is 81% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on United Laboratories International Holdings and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Laboratories International Holdings's current Interest Coverage is 2.42, which is 85% below median its own 10-year median of 15.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
Based on GuruFocus' analysis, United Laboratories International Holdings (STU:UNJ) is currently considered Fairly Valued. The stock's GF Value™ is €0.93, compared to a current price of €1.00 — trading 7% above its estimated fair value. The current Interest Coverage is 2.42, which is 85% below median its 10-year median of 15.81 and 81% below the Drug Manufacturers industry median of 12.75. United Laboratories International Holdings' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For United Laboratories International Holdings (STU:UNJ), the current Interest Coverage is 2.42 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is United Laboratories International Holdings (STU:UNJ) Overvalued in 2026?
Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued.
The current stock price of €1.00 is trading 7% above its estimated GF Value™ of €0.93.
GuruFocus considers United Laboratories International Holdings to be Fairly Valued.
Key valuation signals for STU:UNJ:
Interest Coverage: 2.42 (85% below median its 10-year median of 15.81)
GF Value™: €0.93 vs. price of €1.00 (7% above fair value)
Industry Position: 81% below the Drug Manufacturers median (#225 of 687)
No single metric tells the full story. See the STU:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
United Laboratories International Holdings Business Description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
65GF Score
Get the complete analysis for STU:UNJ
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:UNJ has been successfully added to your 
